A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors
NCT07173244
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Gastrointestinal Cancers
Interventions
DRUG:
Adebrelimab
Sponsor
Tianjin First Central Hospital